Location History:
- Stockholm, SE (2010 - 2012)
- Uppsala, SE (2000 - 2013)
Company Filing History:
6 out of 15 
1 out of 1 
1 out of 10 Years Active: 2000-2025
Title: The Innovative Contributions of Anders Rudolf Hallberg
Introduction
Anders Rudolf Hallberg is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various medical conditions. With a total of 8 patents to his name, Hallberg's work has the potential to impact the treatment of autoimmune and fibrotic diseases.
Latest Patents
Among his latest patents are the "Selective angiotensin II compounds," which provide pharmaceutical compounds useful in treating autoimmune and fibrotic diseases, including interstitial lung diseases such as idiopathic pulmonary fibrosis and sarcoidosis. Another significant patent is for "Bicyclic angiotensin II agonists," which describes compounds that serve as selective agonists of the AT2 receptor. These compounds are particularly useful in treating gastrointestinal conditions like dyspepsia, IBS, and MOF, as well as cardiovascular disorders.
Career Highlights
Throughout his career, Hallberg has worked with several prominent companies, including Vicore Pharma AB and Labwell AB. His expertise in pharmaceutical development has allowed him to contribute to innovative solutions in the medical field.
Collaborations
Hallberg has collaborated with notable professionals in his field, including Mathias Alterman and Mats Larhed. These partnerships have further enhanced his research and development efforts.
Conclusion
Anders Rudolf Hallberg's contributions to pharmaceutical innovation are noteworthy, with a focus on developing compounds that address critical health issues. His work continues to pave the way for advancements in medical treatments.